Recent News

• 06.10.2025 - Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
• 06.09.2025 - Neurocrine Biosciences Appoints Lewis Choi as Chief Information Officer
• 06.02.2025 - Neurocrine Biosciences Presents Patient-Reported Outcomes from KINECT-PRO™ Study Demonstrating INGREZZA® (valbenazine) Capsules Improved Functionality and Quality of Life in Patients with Tardive Dyskinesia
• 05.28.2025 - Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025

Recent Filings

• 06.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.04.2025 - 3 Initial statement of beneficial ownership of securities
• 05.30.2025 - 8-K Current report
• 05.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.27.2025 - 144 Report of proposed sale of securities
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities